Molecular study of Pompe disease in Egyptian infants
Abstract Background Pompe disease (PD) is a serious genetic disorder caused by deficiency of acid α-glucosidase (GAA) and subsequent glycogen accumulation inside lysosomes. This study included a cohort of 5 Egyptian infants (1–8 months old) with far lower than average normal GAA activity and clinica...
Saved in:
Main Authors: | Mona Essawi, Nagham ElBagoury, Engy Ashaat, Wessam Sharaf-Eldin, Ekram Fateen |
---|---|
Format: | article |
Language: | EN |
Published: |
SpringerOpen
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/80b1f9edba774b38a0beb7b458a44e09 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
by: Antonietta Tarallo, et al.
Published: (2021) -
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
by: Alícia Dorneles Dornelles, et al.
Published: (2021) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
by: Javier de las Heras, et al.
Published: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
by: Zhang B, et al.
Published: (2016) -
Fabrication and Biological Assessment of Antidiabetic α-Mangostin Loaded Nanosponges: In Vitro, In Vivo, and In Silico Studies
by: Faisal Usman, et al.
Published: (2021)